<VariationArchive VariationID="848365" VariationName="NM_001040142.2(SCN2A):c.1530_1531del (p.Lys511fs)" VariationType="Deletion" Accession="VCV000848365" Version="5" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-01" DateCreated="2020-04-15" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="825059" VariationID="848365">
      <GeneList>
        <Gene Symbol="SCN2A" FullName="sodium voltage-gated channel alpha subunit 2" GeneID="6326" HGNC_ID="HGNC:10588" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165239414" stop="165392304" display_start="165239414" display_stop="165392304" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="166095911" stop="166248819" display_start="166095911" display_stop="166248819" Strand="+" />
          </Location>
          <OMIM>182390</OMIM>
          <Haploinsufficiency last_evaluated="2020-04-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCN2A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-04-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCN2A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001040142.2(SCN2A):c.1530_1531del (p.Lys511fs)</Name>
      <CanonicalSPDI>NC_000002.12:165315615:AGA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165315616" stop="165315617" display_start="165315616" display_stop="165315617" variantLength="2" positionVCF="165315615" referenceAlleleVCF="CAG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="166172126" stop="166172127" display_start="166172126" display_stop="166172127" variantLength="2" positionVCF="166172125" referenceAlleleVCF="CAG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>K511fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.166172127_166172128del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.166172127_166172128del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.165315617_165315618del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.165315617_165315618del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008143.1" sequenceAccession="NG_008143" sequenceVersion="1" change="g.81216_81217del">
            <Expression>NG_008143.1:g.81216_81217del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001040142.2" sequenceAccession="NM_001040142" sequenceVersion="2" change="c.1530_1531del" MANESelect="true">
            <Expression>NM_001040142.2:c.1530_1531del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001035232.1" sequenceAccession="NP_001035232" sequenceVersion="1" change="p.Lys511fs">
            <Expression>NP_001035232.1:p.Lys511fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001040143.2" sequenceAccession="NM_001040143" sequenceVersion="2" change="c.1530_1531del">
            <Expression>NM_001040143.2:c.1530_1531del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001035233.1" sequenceAccession="NP_001035233" sequenceVersion="1" change="p.Lys511fs">
            <Expression>NP_001035233.1:p.Lys511fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001371246.1" sequenceAccession="NM_001371246" sequenceVersion="1" change="c.1530_1531del" MANEPlusClinical="true">
            <Expression>NM_001371246.1:c.1530_1531del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001358175.1" sequenceAccession="NP_001358175" sequenceVersion="1" change="p.Lys511fs">
            <Expression>NP_001358175.1:p.Lys511fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001371247.1" sequenceAccession="NM_001371247" sequenceVersion="1" change="c.1530_1531del">
            <Expression>NM_001371247.1:c.1530_1531del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001358176.1" sequenceAccession="NP_001358176" sequenceVersion="1" change="p.Lys511fs">
            <Expression>NP_001358176.1:p.Lys511fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_021007.3" sequenceAccession="NM_021007" sequenceVersion="3" change="c.1530_1531del">
            <Expression>NM_021007.3:c.1530_1531del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_066287.2" sequenceAccession="NP_066287" sequenceVersion="2" change="p.Lys511fs">
            <Expression>NP_066287.2:p.Lys511fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_021007.2" sequenceAccession="NM_021007" sequenceVersion="2" change="c.1530_1531delGA">
            <Expression>NM_021007.2:c.1530_1531delGA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1697702086" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001040142.2(SCN2A):c.1530_1531del (p.Lys511fs) AND multiple conditions" Accession="RCV001052107" Version="3">
        <ClassifiedConditionList TraitSetID="10464">
          <ClassifiedCondition DB="MedGen" ID="C3150987">Developmental and epileptic encephalopathy, 11</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1843140">Seizures, benign familial infantile, 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-02-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001040142.2(SCN2A):c.1530_1531del (p.Lys511fs) AND Inborn genetic diseases" Accession="RCV002400300" Version="2">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-05-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-02-02" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-04-15" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22495306</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23020937</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24650168</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="10464" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15766" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Early infantile epileptic encephalopathy 11</ElementValue>
                <XRef ID="Epileptic+encephalopathy%2C+early+infantile%2C+11/8339" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 11</ElementValue>
                <XRef ID="MONDO:0013388" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DEE11</ElementValue>
                <XRef Type="MIM" ID="613721" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15699" />
                <XRef ID="15699" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="1934" DB="Orphanet" />
              <XRef ID="C3150987" DB="MedGen" />
              <XRef ID="MONDO:0013388" DB="MONDO" />
              <XRef Type="MIM" ID="613721" DB="OMIM" />
            </Trait>
            <Trait ID="1007" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Familial neonatal seizures</ElementValue>
                <XRef ID="279953009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CONVULSIONS, BENIGN FAMILIAL INFANTILE, 3</ElementValue>
                <XRef Type="MIM" ID="607745" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Seizures, benign familial infantile, 3</ElementValue>
                <XRef ID="MONDO:0011904" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BFIC3</ElementValue>
                <XRef Type="MIM" ID="607745" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">BFIS3</ElementValue>
                <XRef Type="MIM" ID="607745" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BFNIS</ElementValue>
                <XRef Type="MIM" ID="607745" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1518" />
                <XRef ID="1518" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <XRef ID="140927" DB="Orphanet" />
              <XRef ID="306" DB="Orphanet" />
              <XRef ID="C1843140" DB="MedGen" />
              <XRef ID="MONDO:0011904" DB="MONDO" />
              <XRef Type="MIM" ID="607745" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2381710" SubmissionDate="2022-05-04" DateLastUpdated="2022-05-16" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="5960326|MedGen:C1843140;C3150987" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001216300" DateUpdated="2022-05-16" DateCreated="2020-04-15" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-02-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22495306</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23020937</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24650168</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Lys511Argfs*10) in the SCN2A gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with SCN2A-related conditions. Loss-of-function variants in SCN2A are known to be pathogenic (PMID: 22495306, 23020937, 24650168). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.166172126_166172127del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1843140" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3150987" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5189251" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a467300|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002709695" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-05-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.1530_1531delGA pathogenic mutation, located in coding exon 10 of the SCN2A gene, results from a deletion of two nucleotides at nucleotide positions 1530 to 1531, causing a translational frameshift with a predicted alternate stop codon (p.K511Rfs*10). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_021007.2:c.1530_1531delGA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2381710" TraitType="Disease" MappingType="XRef" MappingValue="C1843140" MappingRef="MedGen">
        <MedGen CUI="C1843140" Name="Seizures, benign familial infantile, 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2381710" TraitType="Disease" MappingType="XRef" MappingValue="C3150987" MappingRef="MedGen">
        <MedGen CUI="C3150987" Name="Developmental and epileptic encephalopathy, 11" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5189251" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

